These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 35947749)

  • 21. CRISPR-Cas systems are present predominantly on mobile genetic elements in Vibrio species.
    McDonald ND; Regmi A; Morreale DP; Borowski JD; Boyd EF
    BMC Genomics; 2019 Feb; 20(1):105. PubMed ID: 30717668
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Crystal structure of the anti-CRISPR repressor Aca2.
    Usher B; Birkholz N; Beck IN; Fagerlund RD; Jackson SA; Fineran PC; Blower TR
    J Struct Biol; 2021 Sep; 213(3):107752. PubMed ID: 34116143
    [TBL] [Abstract][Full Text] [Related]  

  • 23. CasPDB: an integrated and annotated database for Cas proteins from bacteria and archaea.
    Tang Z; Chen S; Chen A; He B; Zhou Y; Chai G; Guo F; Huang J
    Database (Oxford); 2019 Jan; 2019():. PubMed ID: 31411686
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Insights into the inhibition of type I-F CRISPR-Cas system by a multifunctional anti-CRISPR protein AcrIF24.
    Yang L; Zhang L; Yin P; Ding H; Xiao Y; Zeng J; Wang W; Zhou H; Wang Q; Zhang Y; Chen Z; Yang M; Feng Y
    Nat Commun; 2022 Apr; 13(1):1931. PubMed ID: 35411005
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Multifactorial control of the expression of a CRISPR-Cas system by an extracytoplasmic function σ/anti-σ pair and a global regulatory complex.
    Bernal-Bernal D; Abellón-Ruiz J; Iniesta AA; Pajares-Martínez E; Bastida-Martínez E; Fontes M; Padmanabhan S; Elías-Arnanz M
    Nucleic Acids Res; 2018 Jul; 46(13):6726-6745. PubMed ID: 29893914
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Covalent Modifications of the Bacteriophage Genome Confer a Degree of Resistance to Bacterial CRISPR Systems.
    Liu Y; Dai L; Dong J; Chen C; Zhu J; Rao VB; Tao P
    J Virol; 2020 Nov; 94(23):. PubMed ID: 32938767
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Discovery of widespread type I and type V CRISPR-Cas inhibitors.
    Marino ND; Zhang JY; Borges AL; Sousa AA; Leon LM; Rauch BJ; Walton RT; Berry JD; Joung JK; Kleinstiver BP; Bondy-Denomy J
    Science; 2018 Oct; 362(6411):240-242. PubMed ID: 30190308
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Regulation of PTS gene expression by the homologous transcriptional regulators, Mlc and NagC, in Escherichia coli (or how two similar repressors can behave differently).
    Plumbridge J
    J Mol Microbiol Biotechnol; 2001 Jul; 3(3):371-80. PubMed ID: 11361067
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Francisella novicida CRISPR-Cas Systems Can Functionally Complement Each Other in DNA Defense while Providing Target Flexibility.
    Ratner HK; Weiss DS
    J Bacteriol; 2020 May; 202(12):. PubMed ID: 32284320
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cas9 degradation in human cells using phage anti-CRISPR proteins.
    Meacham Z; de Tacca LA; Bondy-Denomy J; Rabuka D; Schelle M
    PLoS Biol; 2023 Dec; 21(12):e3002431. PubMed ID: 38064533
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Glycine Cleavage System and cAMP Receptor Protein Co-Regulate CRISPR/
    Yang D; Wang Z; Ma J; Fu Q; Wu L; Wang H; Wang S; Yan Y; Sun J
    Viruses; 2020 Jan; 12(1):. PubMed ID: 31941083
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Repressor for the sn-glycerol 3-phosphate regulon of Escherichia coli K-12: primary structure and identification of the DNA-binding domain.
    Zeng G; Ye S; Larson TJ
    J Bacteriol; 1996 Dec; 178(24):7080-9. PubMed ID: 8955387
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Regulation of the Type I-F CRISPR-Cas system by CRP-cAMP and GalM controls spacer acquisition and interference.
    Patterson AG; Chang JT; Taylor C; Fineran PC
    Nucleic Acids Res; 2015 Jul; 43(12):6038-48. PubMed ID: 26007654
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Asymmetric positioning of Cas1-2 complex and Integration Host Factor induced DNA bending guide the unidirectional homing of protospacer in CRISPR-Cas type I-E system.
    Yoganand KN; Sivathanu R; Nimkar S; Anand B
    Nucleic Acids Res; 2017 Jan; 45(1):367-381. PubMed ID: 27899566
    [TBL] [Abstract][Full Text] [Related]  

  • 35. CvkR is a MerR-type transcriptional repressor of class 2 type V-K CRISPR-associated transposase systems.
    Ziemann M; Reimann V; Liang Y; Shi Y; Ma H; Xie Y; Li H; Zhu T; Lu X; Hess WR
    Nat Commun; 2023 Feb; 14(1):924. PubMed ID: 36801863
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Repurposing endogenous type I CRISPR-Cas systems for programmable gene repression.
    Luo ML; Mullis AS; Leenay RT; Beisel CL
    Nucleic Acids Res; 2015 Jan; 43(1):674-81. PubMed ID: 25326321
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Identification, nucleotide sequence, and characterization of PspF, the transcriptional activator of the Escherichia coli stress-induced psp operon.
    Jovanovic G; Weiner L; Model P
    J Bacteriol; 1996 Apr; 178(7):1936-45. PubMed ID: 8606168
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sequence specific integration by the family 1 casposase from Candidatus Nitrosopumilus koreensis AR1.
    Wang X; Yuan Q; Zhang W; Ji S; Lv Y; Ren K; Lu M; Xiao Y
    Nucleic Acids Res; 2021 Sep; 49(17):9938-9952. PubMed ID: 34428286
    [TBL] [Abstract][Full Text] [Related]  

  • 39. StpA represses CRISPR-Cas immunity in H-NS deficient Escherichia coli.
    Mitić D; Radovčić M; Markulin D; Ivančić-Baće I
    Biochimie; 2020 Jul; 174():136-143. PubMed ID: 32353388
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Type I-E CRISPR-Cas System as a Defense System in Saccharomyces cerevisiae.
    Bindal G; Amlinger L; Lundgren M; Rath D
    mSphere; 2022 Jun; 7(3):e0003822. PubMed ID: 35473305
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.